**Klotho Neuroscience Inc. Receives Nasdaq Delisting Warning** Klotho Neuroscience Inc. announced it has received a delinquency notification from the Nasdaq Stock Market for failing to maintain a minimum bid price of $1 per share for 30 consecutive business days, as required by Nasdaq Listing Rule 5550(a)(2). The company now has 180 calendar days, until March 18, 2026, to regain compliance by ensuring its closing bid price is at least $1 for ten consecutive business days. If Klotho Neuroscience fails to meet this requirement, its common stock may be delisted from Nasdaq.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klotho Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-091652), on September 25, 2025, and is solely responsible for the information contained therein.
Comments